Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease

Author： Gordon Joshiah Panos Ralph J

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.3, 2010-03, pp. : 381-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Formoterol Monotherapy Compared with Combined Ipratropium Bromide plus Fenoterol in the Treatment of Chronic Obstructive Pulmonary Disease

By Konermann M.

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 235-242

Adis International

Access to resources Recommend Favorite

Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Page Clive P Matera Maria Gabriella

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1205-1214

Informa Healthcare

Access to resources Recommend Favorite

One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease

By Brazinsky S.A.

Clinical Drug Investigation, Vol. 23, Iss. 3, 2003-01 ,pp. : 181-191

Adis International

Access to resources Recommend Favorite

Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Rogliani Paola Matera Maria Gabriella

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 775-781

Informa Healthcare

Access to resources Recommend Favorite

A Review of Ipratropium Bromide/Fenoterol Hydrobromide (Berodual ® ) Delivered Via Respimat ® Soft Mist Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Disease

By Frank Kässner

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1671-1682

Adis International

Access to resources Recommend Favorite